Vital Therapies Inc (VTL) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Vital Therapies Inc (Vital Therapies) is a biotechnology company that discovers, develops and commercialize cell-based therapies. The companys product candidate includes ELAD system, a human-cell-based bio artificial liver treatment designed to allow the patients own liver to regenerate or to stabilize the patient until transplant. It also provides programs for severe acute alcoholic hepatitis and alcohol induced liver decompensation, surgery-induced liver failure, fulminant liver failure, and chronic liver failure. Vital Therapies device is used in the treatment of acute liver failure. The company has operations in the US and China. Vital Therapies is headquartered in San Diego, California, the US.

Vital Therapies Inc (VTL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 5
List of Figures 5
Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Vital Therapies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Vital Therapies Inc, Medical Devices Deals, 2012 to YTD 2018 10
Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Vital Therapies Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Vital Therapies Raises US$32 Million In Venture Financing 12
Vital Therapies Raises US$12 Million In Venture Financing 13
Vital Therapies Increases Size Of Financing To US$100 Million 14
Vital Therapies Secures USD4.35 Million in Venture Funding 16
Equity Offering 17
Vital Therapies Plans to Raise Funds through Public Offering of Shares 17
Vital Therapies Plans to Raise USD200 Million in Public Offering of Securities 18
Vital Therapies Raises USD40.3 Million in Public Offering of Shares 19
Vital Therapies Raises USD12.2 Million in Public Offering of Shares 21
Vital Therapies Raises USD34.5 Million in Public Offering of Shares 22
Vital Therapies Completes Partial Exercise of Underwriters Over Allotment Option of Public Offering of Shares for USD36 Million 24
Vital Therapies Completes Underwriters Exercise Of Full Over-Allotment Option Of IPO For US$62.1 Million 26
Vital Therapies Inc - Key Competitors 28
Vital Therapies Inc - Key Employees 29
Vital Therapies Inc - Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Financial Announcements 31
May 08, 2018: Vital Therapies Reports First Quarter 2018 Financial Results 31
Mar 13, 2018: Vital Therapies Announces Fourth Quarter and Full Year 2017 Financial Results 32
Oct 25, 2017: Vital Therapies Announces Third Quarter 2017 Financial Results 34
Aug 03, 2017: Vital Therapies Announces Second Quarter 2017 Financial Results 35
May 09, 2017: Vital Therapies Announces First Quarter 2017 Financial Results 36
Mar 07, 2017: Vital Therapies Announces Fourth Quarter and Full Year 2016 Financial Results 37
Corporate Communications 38
Dec 11, 2017: Vital Therapies Added to NASDAQ Biotechnology Index 38
Sep 06, 2017: Vital Therapies Appoints Former Receptos President and CEO Faheem Hasnain as Chairman of the Board of Directors 39
Product News 40
12/04/2017: Vital Therapies Appoints Russell J. Cox as Chief Executive Officer and Board Member Effective January 3, 2018 40
09/06/2017: Vital Therapies Appoints Former Receptos President and CEO Faheem Hasnain as Chairman of the Board of Directors 41
Clinical Trials 42
Mar 22, 2018: Vital Therapies Announces VTL-308 Reaches Enrollment Target of 150 Subjects 42
Jun 05, 2017: Vital Therapies Announces Characteristics of Early Subjects in VTL-308 Pivotal Study of ELAD System in Severe Alcoholic Hepatitis 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List Of Tables

List of Tables
Vital Therapies Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Vital Therapies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Vital Therapies Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Vital Therapies Inc, Medical Devices Deals, 2012 to YTD 2018 10
Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Vital Therapies Raises US$32 Million In Venture Financing 12
Vital Therapies Raises US$12 Million In Venture Financing 13
Vital Therapies Increases Size Of Financing To US$100 Million 14
Vital Therapies Secures USD4.35 Million in Venture Funding 16
Vital Therapies Plans to Raise Funds through Public Offering of Shares 17
Vital Therapies Plans to Raise USD200 Million in Public Offering of Securities 18
Vital Therapies Raises USD40.3 Million in Public Offering of Shares 19
Vital Therapies Raises USD12.2 Million in Public Offering of Shares 21
Vital Therapies Raises USD34.5 Million in Public Offering of Shares 22
Vital Therapies Completes Partial Exercise of Underwriters Over Allotment Option of Public Offering of Shares for USD36 Million 24
Vital Therapies Completes Underwriters Exercise Of Full Over-Allotment Option Of IPO For US$62.1 Million 26
Vital Therapies Inc, Key Competitors 28
Vital Therapies Inc, Key Employees 29
Vital Therapies Inc, Subsidiaries 30

List Of Figures

List of Figures
Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Vital Therapies Inc, Medical Devices Deals, 2012 to YTD 2018 10

Vital Therapies Inc (VTL) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Vital Therapies Inc (Vital Therapies) is a biotechnology company that discovers, develops and commercialize cell-based therapies. The companys product candidate includes ELAD system, a human-cell-based bio artificial liver treatment designed

USD 250 View Report

Vital Therapies Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Vital Therapies Inc Company Profile is a detailed strategic and analytical report on Vital Therapies Inc. The 2018 version of the report offers detailed insights into the companys strategies, developments,

USD 200 View Report

Intra-Cellular Therapies Inc (ITCI) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Intra-Cellular Therapies Inc (ITI) is a novel drug manufacturer. The company offers product platform such as ITCI Pipeline that includes lumateperone, ITI-007 platform, PDE inhibitor platform and drug discovery platform.

USD 250 View Report

AZTherapies Inc - Pharmaceuticals and Healthcare - Deals and Alliances Profile

AZTherapies Inc (AZTherapies) is a clinical-stage drug development company that offers discovery, development and commercialization of novel Alzheimers disease therapeutics. The companys product pipeline includes the lead product candidate ALZT-OP1,

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available